- Home
- VTR vs DXCM Comparison
VTR vs DXCM Comparison
Compare VTR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTR | DXCM |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.1B | 26.5B |
| IPO Year | 2005 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VTR | DXCM |
|---|---|---|
| Price | $85.86 | $67.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 21 |
| Target Price | $84.77 | ★ $85.33 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | ★ 184.21 | 47.18 |
| EPS | 0.54 | ★ 2.09 |
| Revenue | ★ $5,833,980,000.00 | N/A |
| Revenue This Year | $13.68 | $14.48 |
| Revenue Next Year | $8.35 | $12.39 |
| P/E Ratio | $161.81 | ★ $32.35 |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $60.15 | $54.11 |
| 52 Week High | $88.37 | $89.07 |
Technical Indicators
Market Signals| Indicator | VTR | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 44.52 |
| Support Level | $83.96 | $63.69 |
| Resistance Level | $87.56 | $69.38 |
| Average True Range (ATR) | 1.49 | 1.88 |
| MACD | -0.22 | -0.31 |
| Stochastic Oscillator | 42.52 | 39.45 |
Price Performance
Historical ComparisonAbout VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.